Novel FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer
by Vall d'Hebron Institute of OncologyIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithel
Updated on: January 11,2024
Novel FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer
by Vall d'Hebron Institute of OncologyIntermediate magnification micrograph of a low malignant potential (LMP) mucinous ovarian tumour. H&E stain. The micrograph shows: Simple mucinous epithel
Updated on:January 11,2024
